EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen

Bernice Nounamo, Fariba Jousheghany, Eric Robb Siegel iD, Steven R Post iD, Thomas Kelly iD, Soldano Ferrone iD, Thomas Kieber-Emmons, Behjatolah Monzavi-Karbassi

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bernice Nounamo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA. Hauptthemen laut MEDLINE: Proteoglycans, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anti-CSPG4 monoclonal antibodies (mAbs) have shown anti-tumor activity and therapeutic potential for treating breast cancer. In addition, CSPG4 is a dominant tumor-associated antigen that is also involved in normal-tissue development in humans. Therefore, the potential for off-tumor activity remains a serious concern when targeting CSPG4 therapeutically. Previous work suggested that glycans contribute to the binding of specific anti-CSPG4 antibodies to tumor cells, but the specificity and importance of this contribution are unknown. In this study, the reactivity of anti-CSPG4 mAbs was characterized with a peptide mimetic of carbohydrate antigens expressed in breast cancer. ELISA, flow cytometry, and microarray assays were used to screen mAbs for their ability to bind to carbohydrate-mimicking peptides (CMPs), cancer cells, and glycans. The mAb VT68.2 displayed a distinctly strong binding to a CMP (P10s) and bound to triple-negative breast cancer cells. In addition, VT68.2 showed a higher affinity for N-linked glycans that contain terminal fucose and fucosylated lactosamines. The functional assays demonstrated that VT68.2 inhibited cancer cell migration. These results define the glycoform reactivity of an anti-CSPG4 antibody and may lead to the development of less toxic therapeutic approaches that target tumor-specific glyco-peptides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteoglycansTriple Negative Breast NeoplasmsHumansChondroitin Sulfate ProteoglycansAntibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateMembrane ProteinsChondroitin Sulfate Proteoglycan 4

Stichwörter der Autor:innen

CSPG4TACAsbreast cancercarbohydrate-mimicking peptide

Substanzen

ProteoglycansChondroitin Sulfate ProteoglycansAntibodies, MonoclonalAntigens, Tumor-Associated, CarbohydrateMembrane ProteinsChondroitin Sulfate Proteoglycan 4CSPG4 protein, human

Autor:innen und Institutionen

  • Department of Pathology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA.
  • Department of Biostatistics, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA.
  • Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA.
  • Department of Surgery, Massachusetts General Hospital, Yaw 7, 55 Fruit St, Boston, MA 02114, USA.

ORCID-Profile: Eric Robb Siegel, Steven R Post, Thomas Kelly, Soldano Ferrone

Förderung

  • NIGMS NIH HHS
  • NCATS NIH HHS
  • National Institute of Health
  • Arkansas Biosciences Institute
  • Center for Microbial Pathogenesis and Host Inflammatory Responses

Zitieren

APA

Nounamo, B., Jousheghany, F., Siegel, E. R., Post, S. R., Kelly, T., Ferrone, S., Kieber-Emmons, T., & Monzavi-Karbassi, B. (2023). VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032506

Vancouver

Nounamo B, Jousheghany F, Siegel ER, Post SR, Kelly T, Ferrone S, et al. VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032506

BibTeX
@article{Nounamo2023,
  author = {Nounamo, Bernice and Jousheghany, Fariba and Siegel, Eric Robb and Post, Steven R and Kelly, Thomas and Ferrone, Soldano and Kieber-Emmons, Thomas and Monzavi-Karbassi, Behjatolah},
  title = {VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032506}
}
Kostenlos starten →